戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  able to encapsulate small molecules such as sulforhodamine.
2                         The fluorescent dyes sulforhodamine 101 (SR 101) and FM1-43 were used as acti
3                                              Sulforhodamine 101 (SR101) is a preferential astrocyte m
4 aging, we showed that the fluorescent anions sulforhodamine 101 (SR101), fluorescein methotrexate (FL
5 e used a sensitive activity-dependent probe, sulforhodamine 101 (SR101), to view endocytic events wit
6 cumulation of the fluorescent organic anions sulforhodamine 101 and fluorescein methotrexate was also
7     The method is based on the peroxyoxalate/sulforhodamine 101 chemiluminescence reaction, with SPE
8                                              Sulforhodamine 101 imaging showed that double fusion por
9 lm on the silver, the coupling efficiency of sulforhodamine 101 in PVA ranged from 30 to 49%.
10                       The activity-dependent sulforhodamine 101 uptake after the trigeminal and hypog
11 green dye, calcein, and a reference red dye, sulforhodamine 101, after pulsed iontophoretic infusion.
12 es lacking a chelation site, fluorescein and sulforhodamine 101, implicating the fluorophore itself a
13 , combined with activity-dependent uptake of sulforhodamine 101, peripheral hypoglossal and trigemina
14                       The astrocytic marker, sulforhodamine 101, stained the fusion-produced membrane
15 le-cell indicators of glutamate transport in sulforhodamine 101-positive astrocytes of Q175 mice, a k
16 , and astrocytes were selectively stained by sulforhodamine 101.
17  processes labeled by a Ca(2+) indicator and sulforhodamine 101.
18 d as uptake of the fluorescent optical probe sulforhodamine 101.
19                          The introduction of sulforhodamine, a fluorophore that is not taken up by sy
20 es were expressed, labeled with bifunctional sulforhodamine, and exchanged into demembranated trabecu
21                                        Using sulforhodamine as a model hydrophilic drug, rates of dif
22                                              Sulforhodamine B (monosodium salt) exhibited a fold chan
23        The novel EPD delivered more than 80% sulforhodamine b (SRB) and model antigen ovalbumin (OVA)
24 somes both encapsulating the fluorescent dye sulforhodamine B (SRB) and with SRB tagged to lipids in
25 garding their growth inhibitory activity, by sulforhodamine B (SRB) assay.
26                                Water-soluble sulforhodamine B (SRB) was loaded into the aqueous inter
27 lindrical PEO microdomains containing 10 muM sulforhodamine B (SRB) was prepared by directional solve
28 was to visualize the transdermal delivery of sulforhodamine B (SRB), a fluorescent hydrophilic permea
29  vaccine delivery as a much higher amount of sulforhodamine B (SRB), methylene blue (MB) or a model v
30 zol-2-yl)-2,5-diphenyltetrazolium bromide or sulforhodamine B analysis.
31 dimethylthiazol-2,5-diphenyl)tetrazolium and sulforhodamine B analysis] and interstrand DNA cross-lin
32                         A combination of the sulforhodamine B and propidium iodide/Hoechst assays wou
33                                         Both sulforhodamine B and rhodamine B hexyl ester were observ
34 rophilic and hydrophobic fluorescent probes, sulforhodamine B and rhodamine B hexyl ester, in excised
35                          The sensor utilizes sulforhodamine B as a fluorescent reporter dye encapsula
36               Cell viability was measured by sulforhodamine B assay and also lactate dehydrogenase as
37                                          The sulforhodamine B assay gave valid results, but measures
38 and apoptotic effects) was determined by the sulforhodamine B assay, which measures the cellular prot
39 also evaluated in three cancer cell lines by sulforhodamine B assay.
40  anticancer drug-screening method based on a sulforhodamine B assay.
41                                     Based on sulforhodamine B assays for the number of viable cells,
42 mass spectrometry, dialysis equilibrium, and sulforhodamine B assays).
43 ant step of the fusion process, we entrapped sulforhodamine B at self-quenching concentrations into l
44 ared and functionalized with rose bengal and sulforhodamine B by a ligand-exchange procedure.
45               T-tubules were visualized with sulforhodamine B dye.
46 s derived from the ortho and para isomers of sulforhodamine B fluorophores and demonstrated they are
47 ransport properties of the hydrophilic probe sulforhodamine B included increases in the vehicle to sk
48 mers with a precisely core positioned single sulforhodamine B molecule.
49 Cell growth inhibition was measured with the sulforhodamine B protein dye assay.
50 rmined in HeLa, MCF7 and MRC-5 cell lines by sulforhodamine B test.
51 lar mass fluorescent dyes Lucifer Yellow and Sulforhodamine B with the single vessel occlusion techni
52 ol) and two model compounds (fluorescein and sulforhodamine B) from porous media following evaporatio
53 ion (percent leakage of the fluorescent dye, Sulforhodamine B) over the entire studied concentration
54 l ester, and of the model hydrophilic probe, sulforhodamine B, for this 400-skin-site study exhibited
55                                        Using sulforhodamine b, zidovudine, and bovine serum albumin a
56 gged liposomes encapsulating the marker dye, sulforhodamine B.
57 orbance endpoint by the protein-staining dye sulforhodamine B.
58 delivery of two model fluorescent molecules, sulforhodamine-B and FITC-insulin in vitro, and absorpti
59 ose-dependent permeation of FITC-insulin and sulforhodamine-B.
60 ess hydrophilic carboxyrhodamine compared to sulforhodamine can more readily penetrate through the ce
61                                              Sulforhodamine-containing vesicles were shown by fluores
62 etected at distances of 5 and 10 mm from the sulforhodamine donor reservoir at 4 hours and 3 days, re
63           A new type of a highly fluorescent sulforhodamine dye, 221SR, was designed and synthesized
64 is study shows that the lateral diffusion of sulforhodamine in human sclera is slow and localizes to
65 h Fast Blue in the rat or activity-dependent sulforhodamine-labeled neurons in the turtle were used t
66 on in vivo and in vitro, we used fluorescent sulforhodamine-linked laminari-oligosaccharides as artif
67 ger cysteine-reactive methanethiosulfonates [sulforhodamine-methanethiosulfonate and 2-((biotinoyl)am
68 T were expressed in oocytes and labeled with sulforhodamine-MTS.
69 ll walls of this strain, when incubated with sulforhodamine-oligosaccharide, also showed Crhp-depende
70 ing polarized fluorescence from bifunctional sulforhodamine probes.
71         The effective lateral diffusivity of sulforhodamine was determined to be 3.82 x 10(-6) cm2/s,
72                        Measurable amounts of sulforhodamine were detected at distances of 5 and 10 mm
73 lifetime-based nanoprobe based on lipophilic sulforhodamine, which stains 2D and 3D cell models, show
74                 On the other hand, replacing sulforhodamine with a carboxyrhodamine produced drastic